» Articles » PMID: 7491891

Fatty Acid Pool Size in Plasma Lipoprotein Fractions of Cystic Fibrosis Patients

Overview
Journal Am J Clin Nutr
Publisher Elsevier
Date 1995 Dec 1
PMID 7491891
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of this study was to quantitatively measure the essential fatty acid pools in lipid fractions of plasma lipoproteins and the alteration of these pool sizes after consumption of a physiologic intake of fish oil. Twenty-three cystic fibrosis (CF) patients and 21 normal subjects were supplemented with fish oil, providing 35 mg n-3 fatty acids/kg body wt for 4 wk. Blood was collected pre- and postsupplementation and was quantitatively analyzed to determine the fatty acid pool size in each lipid class of low-density lipoproteins (LDLs), high-density lipoproteins (HDLs), and very-low-density lipoproteins. Two 7-d food records were collected to determine total fat and fatty acid intakes. Intakes of protein, carbohydrate, and fat as a percentage of energy and the ratio of polyunsaturated to saturated fats was similar for the CF and control groups. Energy intake was greater for CF subjects. Smaller lipoprotein essential fatty acid pools were observed in CF patients than in control subjects. Healthy subjects had larger essential fatty acid pool sizes in cholesterol ester fractions of HDLs and LDLs than CF subjects. Cholesterol ester and phosphatidylcholine pools transported the majority of essential fatty acids in both CF and control subjects.

Citing Articles

Changes of Erythrocyte Fatty Acids after Supplementation with Highly Concentrated Docosahexaenoic Acid (DHA) in Pediatric Cystic Fibrosis: A Randomized Double-Blind Controlled Trial.

Ayats-Vidal R, Bosque-Garcia M, Cordobilla B, Asensio-De la Cruz O, Garcia-Gonzalez M, Castro-Marrero J J Clin Med. 2023; 12(11).

PMID: 37297899 PMC: 10253750. DOI: 10.3390/jcm12113704.


Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.

NTimbane T, Comte B, Mailhot G, Berthiaume Y, Poitout V, Prentki M Clin Biochem Rev. 2009; 30(4):153-77.

PMID: 20011209 PMC: 2791770.


A novel lipidomic strategy reveals plasma phospholipid signatures associated with respiratory disease severity in cystic fibrosis patients.

Guerrera I, Astarita G, Jais J, Sands D, Nowakowska A, Colas J PLoS One. 2009; 4(11):e7735.

PMID: 19893743 PMC: 2768907. DOI: 10.1371/journal.pone.0007735.


Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiency.

Peretti N, Marcil V, Drouin E, Levy E Nutr Metab (Lond). 2005; 2(1):11.

PMID: 15869703 PMC: 1134666. DOI: 10.1186/1743-7075-2-11.